This phenomenon was confirmed by another cross-sectional study, showing that familial combined hyperlipidaemia (FCH) patients had a significantly increased prevalence of DM (13%) vs an FH group with LDLR mutations (2%) (Table 1) (Skoumas et al., 2007). This evidence concerns the gene LDLR and familial hyperaldosteronism.